Clinical trial
Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes
NCT04461236 is registered in ClinicalTrials.gov with Texas A&M University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes
- Lead sponsor
- Texas A&M University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 30, 2019
- Completion date
- March 2, 2020
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes